These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15598426

  • 1. Nitric oxide synthesis contributes to inhibition of graft-versus-tumor-effects against intraperitoneal Meth A tumor.
    Song EK, Lee NR, Sohn MH, Kwak JY, Yim CY.
    Cell Immunol; 2004 Aug; 230(2):109-18. PubMed ID: 15598426
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor.
    Yim CY, McGregor JR, Kwon OD, Bastian NR, Rees M, Mori M, Hibbs JB, Samlowski WE.
    J Immunol; 1995 Nov 01; 155(9):4382-90. PubMed ID: 7594598
    [Abstract] [Full Text] [Related]

  • 3. Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
    Stelljes M, Specht C, Albring J, Volkmann S, Schlösser V, Pauels HG, Poremba C, Bisping G, Opitz C, Scheffold C, Silling G, Kiehl M, Berdel WE, Kienast J.
    Transplantation; 2007 Feb 15; 83(3):314-22. PubMed ID: 17297406
    [Abstract] [Full Text] [Related]

  • 4. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V, Pindjáková J, Zajícová A, Krulová M, Zelezná B, Matousek P, Svoboda P.
    Xenotransplantation; 2005 May 15; 12(3):227-34. PubMed ID: 15807773
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the immunosuppressive effects of nitric oxide in graft vs host disease.
    Hoffman RA, Langrehr JM, Wren SM, Dull KE, Ildstad ST, McCarthy SA, Simmons RL.
    J Immunol; 1993 Aug 01; 151(3):1508-18. PubMed ID: 8335943
    [Abstract] [Full Text] [Related]

  • 6. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
    Lee HJ, Oh YK, Rhee M, Lim JY, Hwang JY, Park YS, Kwon Y, Choi KH, Jo I, Park SI, Gao B, Kim WH.
    J Mol Biol; 2007 Jun 15; 369(4):967-84. PubMed ID: 17475277
    [Abstract] [Full Text] [Related]

  • 7. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers.
    Yim CY, Bastian NR, Smith JC, Hibbs JB, Samlowski WE.
    Cancer Res; 1993 Nov 15; 53(22):5507-11. PubMed ID: 8221691
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice.
    Yim CY, Lee CW, Choi SM, Park SS, Lee SJ, Kim JH, Song JS, Yoo WH, Kwak JY, Sohn MH.
    Korean J Intern Med; 1996 Jun 15; 11(2):93-100. PubMed ID: 8854644
    [Abstract] [Full Text] [Related]

  • 10. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase.
    De Ridder M, Verovski VN, Chiavaroli C, Van den Berge DL, Monsaert C, Law K, Storme GA.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1473-80. PubMed ID: 17056198
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90.
    Shi Y, Hutchins W, Ogawa H, Chang CC, Pritchard KA, Zhang C, Khampang P, Lazar J, Jacob HJ, Rafiee P, Baker JE.
    J Mol Cell Cardiol; 2005 Apr 01; 38(4):625-35. PubMed ID: 15808839
    [Abstract] [Full Text] [Related]

  • 13. Nitric oxide cooperates with glucocorticoids in thymic epithelial cell-mediated apoptosis of double positive thymocytes.
    Cohen O, Kfir-Erenfeld S, Spokoini R, Zilberman Y, Yefenof E, Sionov RV.
    Int Immunol; 2009 Oct 01; 21(10):1113-23. PubMed ID: 19692538
    [Abstract] [Full Text] [Related]

  • 14. Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent.
    Oshikawa T, Okamoto M, Tano T, Uddin Ahmed S, Sasai A, Kan S, Moriya Y, Ryoma Y, Saito M, Sato M.
    Int Immunopharmacol; 2006 May 01; 6(5):764-73. PubMed ID: 16546707
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
    Gauthier N, Lohm S, Touzery C, Chantôme A, Perette B, Reveneau S, Brunotte F, Juillerat-Jeanneret L, Jeannin JF.
    Carcinogenesis; 2004 Sep 01; 25(9):1559-65. PubMed ID: 15059928
    [Abstract] [Full Text] [Related]

  • 17. Macrophage-derived nitric oxide induces apoptosis of rat hepatoma cells in vivo.
    Nishikawa M, Sato EF, Kuroki T, Utsumi K, Inoue M.
    Hepatology; 1998 Dec 01; 28(6):1474-80. PubMed ID: 9828209
    [Abstract] [Full Text] [Related]

  • 18. Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice.
    Kondapaneni M, McGregor JR, Salvemini D, Laubach VE, Samlowski WE.
    J Immunother; 2008 May 01; 31(4):325-33. PubMed ID: 18391763
    [Abstract] [Full Text] [Related]

  • 19. Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes.
    Shen T, Zhu QX, Yang S, Ding R, Ma T, Ye LP, Wang LJ, Liang ZZ, Zhang XJ.
    Toxicology; 2007 Oct 08; 239(3):186-94. PubMed ID: 17719164
    [Abstract] [Full Text] [Related]

  • 20. Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2.
    Song MY, Yim JY, Yim JM, Kang IJ, Rho HW, Kim HS, Yhim HY, Lee NR, Song EK, Kwak JY, Sohn MH, Yim CY.
    J Immunother; 2011 Mar 08; 34(2):149-64. PubMed ID: 21304405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.